Clinical Trial Update: A Clinical Trial of Chidamide Combined With Etoposide in Relapsed or Refractory NK/T-cell Lymphoma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating chidamide combined with etoposide in relapsed or refractory NK/T-cell lymphoma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nk T-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• Etoposide (Etoposide)

Snippet

Sponsor: Mingzhi Zhang | Conditions: NK/T-Cell Lymphoma | Phase 4 | Status: UNKNOWN